Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADT with Radiation for High-Risk Prostate Cancer
NCT00243646Phase 3Terminated
- Sponsor
- Schiffler Cancer Center
- Start
- Aug 2004
- Primary completion
- Jul 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide, bicalutamide in prostate cancer (PCa), sponsored by Schiffler Cancer Center. Started Aug 2004; status: terminated.
02
Drugs
leuprolidebicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00243646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243646.